Versant Capital Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513 | Sell |
151
-788
| -84% | -$2.68K | ﹤0.01% | 2548 |
|
|
2025
Q1 | $3.77K | Sell |
939
-89
| -9% | -$357 | ﹤0.01% | 2126 |
|
|
2024
Q4 | $6.67K | Hold |
1,028
| – | – | ﹤0.01% | 1613 |
|
|
2024
Q3 | $5.7K | Buy |
+1,028
| New | +$5.7K | ﹤0.01% | 1259 |
|
|
2023
Q4 | – | Sell |
-286
| Closed | -$1.58K | – | 1945 |
|
|
2023
Q3 | $1.58K | Buy |
+286
| New | +$1.58K | ﹤0.01% | 1385 |
|